文献速递其他结缔组织病系统性红斑狼疮

先天性心脏传导阻滞患者及其同胞的合并症与长期结局:宫内暴露于Ro/SSA自身抗体

Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero.
PubMed 文献 · Ann Rheum Dis · 2019-02-26

基于瑞典国家患者登记数据,纳入119例先天性心脏传导阻滞(CHB)患者、128例同胞及匹配健康对照,采用Cox比例风险模型分析。CHB患者心血管合并症(心肌病/心衰HR 70.0,脑梗死HR 39.9)、感染及系统性结缔组织病(HR 11.8)风险显著增加;CHB患者及其同胞发生15种常见自身免疫病的风险均升高。

要点

  • CHB患者心肌病/心衰风险显著增高(HR 70.0,95%CI 20.8–235.4)。
  • CHB患者脑梗死风险显著增高(HR 39.9,95%CI 4.5–357.3)。
  • CHB患者及其同胞自身免疫病风险均升高,同胞风险共享。

核心结论

  • CHB患者存在多种心血管、感染及自身免疫疾病风险增加,其中自身免疫风险与同胞共享。

研究设计与样本

  • 基于瑞典国家患者登记的全国性队列研究,纳入CHB患者119例、同胞128例、匹配健康对照1190例及对照同胞1071例,采用Cox比例风险模型分析。

主要发现

  • CHB患者心肌病和/或心衰发生20例(16.8%),对照3例(0.3%),HR 70.0(95%CI 20.8–235.4)。
  • CHB患者脑梗死HR 39.9(95%CI 4.5–357.3)。
  • CHB患者感染风险增高。
  • 起搏器治疗与脑梗死风险降低相关,但与心肌病/心衰及感染风险增加相关。
  • CHB患者系统性结缔组织病风险增高(HR 11.8,95%CI 4.0–11.8);CHB患者及其同胞发生15种常见自身免疫病的风险分别增高(HR 5.7,95%CI 2.83–11.69;HR 3.6,95%CI 1.7–8.0)。

临床怎么用

  • 对CHB患者应长期监测心血管合并症、感染及自身免疫病。
  • CHB患者的同胞也应关注自身免疫病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Congenital heart block (CHB) may develop in fetuses of Ro/SSA autoantibody-positive women. Given the rarity of CHB, information on comorbidity and complications later in life is difficult to systematically collect for large groups of patients. We therefore used nation-wide healthcare registers to investigate comorbidity and outcomes in patients with CHB and their siblings. METHODS: Data from patients with CHB (n= 119) and their siblings (n= 128), all born to anti-Ro/SSA-positive mothers, and from matched healthy controls (n= 1,190) and their siblings (n= 1,071), were retrieved from the Swedish National Patient Register. Analyses were performed by Cox proportional hazard modelling. RESULTS: Individuals with CHB had a significantly increased risk of cardiovascular comorbidity, with cardiomyopathy and/or heart failure observed in 20 (16.8%) patients versus 3 (0.3%) controls, yielding a HR of 70.0 (95% CI 20.8 to 235.4), and with a HR for cerebral infarction of 39.9 (95% CI 4.5 to 357.3). Patients with CHB also had a higher risk of infections. Pacemaker treatment was associated with a decreased risk of cerebral infarction but increased risks of cardiomyopathy/heart failure and infection. The risk of systemic connective tissue disorder was also increased in patients with CHB (HR 11.8, 95% CI 4.0 to 11.8), and both patients with CHB and their siblings had an increased risk to develop any of 15 common autoimmune conditions (HR 5.7, 95% CI 2.83 to 11.69 and 3.6, 95% CI 1.7 to 8.0, respectively). CONCLUSIONS: The data indicate an increased risk of several cardiovascular, infectious and autoimmune diseases in patients with CHB, with the latter risk shared by their siblings.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Mofors J, Eliasson H, Ambrosi A, et al. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero. Ann Rheum Dis. 2019. PMID: 30808622. doi:10.1136/annrheumdis-2018-214406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。